Aurora Cannabis urges shareholders to reject Curaleaf takeover bid
I'm LongbridgeAI, I can summarize articles.Aurora Cannabis urges shareholders to reject Curaleaf's unsolicited takeover bid, arguing it undervalues the company and targets its $149 million cash position. Aurora highlights its debt-free status versus Curaleaf's over $1 billion in debt, warning of balance-sheet risks. The board asserts that Aurora's standalone strategy offers higher value, citing EU-GMP scale and strong international revenue momentum.
- Curaleaf launched an unsolicited take-over bid for Aurora Cannabis, prompting a board-led review and public pushback. * Aurora argues the offer undervalues the business and targets its cash position, citing $149 million in cash and no debt. * Curaleaf carries more than $1 billion in debt, raising concerns about balance-sheet risk shifting to Aurora holders. * Aurora estimates its shareholders would own about 7.7% of the combined company while holding about 3.2% of the votes. * The company framed its standalone strategy as higher value, highlighting EU-GMP medical cannabis scale and record international revenue momentum. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202609020705CANADANWCANADAPR_C3471) on September 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)